210 related articles for article (PubMed ID: 35732984)
1. Predictors of hospitalization in patients with systemic lupus erythematosus: a 10-year cohort study.
Assunção H; Rodrigues M; Prata AR; Luís M; da Silva JAP; Inês L
Clin Rheumatol; 2022 Oct; 41(10):2977-2986. PubMed ID: 35732984
[TBL] [Abstract][Full Text] [Related]
2. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort.
Watson P; Brennan A; Birch H; Fang H; Petri M
Rheumatology (Oxford); 2015 Apr; 54(4):623-32. PubMed ID: 25234659
[TBL] [Abstract][Full Text] [Related]
3. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
[TBL] [Abstract][Full Text] [Related]
4. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort.
Petri M; Genovese M
J Rheumatol; 1992 Oct; 19(10):1559-65. PubMed ID: 1464868
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activity.
Sun F; Zhao L; Wang H; Zhang D; Chen J; Wang X; Li T; Ye S
Lupus Sci Med; 2022 May; 9(1):. PubMed ID: 35606018
[TBL] [Abstract][Full Text] [Related]
6. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
7. Early damage as measured by SLICC/ACR damage index is a predictor of hospitalization in systemic lupus erythematosus (SLE).
Raman L; Yahya F; Ng CM; Sockalingam S; Ramasamy K; Ratnam R; Raja J
Lupus; 2020 Dec; 29(14):1885-1891. PubMed ID: 33040647
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial treatment and minimizing prednisolone are associated with lower risk of infection in SLE: a 24-month prospective cohort study.
Prata AR; Luís M; Assunção H; da Silva JAP; Inês LS
Clin Rheumatol; 2022 Apr; 41(4):1069-1078. PubMed ID: 34782940
[TBL] [Abstract][Full Text] [Related]
9. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
Brunner HI; Jones OY; Lovell DJ; Johnson AM; Alexander P; Klein-Gitelman MS
Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
[TBL] [Abstract][Full Text] [Related]
10. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
Pimentel-Quiroz VR; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Esposto A; García MA; Catoggio LJ; Cardiel MH; Barile LA; Amigo MC; Sato EI; Bonfa E; Borba E; Lavras Costallat LT; Neira OJ; Massardo L; Guibert-Toledano M; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
Lupus; 2019 Aug; 28(9):1101-1110. PubMed ID: 31291843
[TBL] [Abstract][Full Text] [Related]
11. Increased frequency of hospital admissions with active systemic lupus erythematosus disease activity defined by two different disease activity indices: A cohort study.
Wang CL; Koo M; Hsu CW; Lu MC
Lupus; 2023 Jun; 32(7):864-872. PubMed ID: 37165549
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Quintana R; Gómez-Puerta JA; Catoggio LJ; Alvarellos A; Saurit V; Borba E; Sato E; Costallat L; Da Silva NA; Iglesias-Gamarra A; Neira O; Reyes-Llerena G; Cardiel MH; Amigo MC; Acevedo-Vásquez E; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA
J Rheumatol; 2019 Oct; 46(10):1299-1308. PubMed ID: 30824636
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays.
Çetin Ç; Can MG; Öztaşkın S; Yalçınkaya Y; Gül A; İnanç M; Artım Esen B
Lupus; 2024 Mar; 33(3):232-240. PubMed ID: 38195200
[TBL] [Abstract][Full Text] [Related]
14. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
Rúa-Figueroa Í; López-Longo J; Galindo-Izquierdo M; Calvo-Alén J; Del Campo V; Olivé-Marqués A; Pérez-Vicente S; Fernández-Nebro A; Andrés M; Erausquin C; Tomero E; Horcada L; Uriarte E; Freire M; Montilla C; Sánchez-Atrio A; Santos G; Boteanu A; Díez-Álvarez E; Narváez J; Martínez-Taboada V; Silva-Fernández L; Ruiz-Lucea E; Andreu JL; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas J; Pecondón-Español Á; Marras C; Ibáñez-Barceló M; Bonilla G; Torrente V; Castellví I; Alegre JJ; Calvet J; Marenco JL; Raya E; Vázquez T; Quevedo V; Muñoz-Fernández S; Rodríguez-Gómez M; Ibáñez J; Pego-Reigosa JM
Semin Arthritis Rheum; 2017 Aug; 47(1):38-45. PubMed ID: 28259425
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
16. Predictors of improvement in disease activity in first hospitalized patients with systemic lupus erythematosus: a multicenter retrospective study of a Chinese cohort.
Li M; Liang J; Pan W; Liu L; Wu M; Ding F; Hu H; Ding X; Wei H; Zou Y; Qian X; Wang M; Wu J; Tao J; Tan J; Da Z; Zhang M; Li J; Feng X; Wen L; Zhang H; Sun L
Clin Rheumatol; 2022 Nov; 41(11):3355-3362. PubMed ID: 35849245
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for hospitalization in Mexican patients with systemic lupus erythematosus.
García-Cañas IE; Cuevas-Orta E; Herrera-Van Oostdam DA; Abud-Mendoza C; Group L
Lupus; 2024 Jul; 33(8):892-898. PubMed ID: 38670796
[TBL] [Abstract][Full Text] [Related]
18. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
[TBL] [Abstract][Full Text] [Related]
20. Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): Rates, causes, and factors associated with length of stay.
Aldarmaki R; Al Khogali HI; Al Dhanhani AM
Lupus; 2021 Apr; 30(5):845-851. PubMed ID: 33497303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
